Bing Zou

3.3k total citations
117 papers, 2.5k citations indexed

About

Bing Zou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bing Zou has authored 117 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 40 papers in Oncology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bing Zou's work include Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Treatments and Mutations (14 papers). Bing Zou is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Research Studies (19 papers) and Lung Cancer Treatments and Mutations (14 papers). Bing Zou collaborates with scholars based in China, Hong Kong and United States. Bing Zou's co-authors include Qing Gu, Benjamin C.Y. Wong, Hsiang Fu Kung, Harry Hua‐Xiang Xia, Jide Wang, Shui Ping Tu, Hua He, Marie C.M. Lin, Hui Y. Lan and Man‐Fung Yuen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Bing Zou

112 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bing Zou China 29 1.2k 563 359 282 231 117 2.5k
Jung‐Min Kim South Korea 32 1.8k 1.5× 593 1.1× 345 1.0× 303 1.1× 164 0.7× 112 3.6k
Xiaoyu Liu China 29 626 0.5× 439 0.8× 306 0.9× 162 0.6× 232 1.0× 140 2.4k
Chia‐Cheng Chang United States 33 2.0k 1.7× 404 0.7× 542 1.5× 179 0.6× 135 0.6× 128 4.0k
David J. Flint United Kingdom 28 1.0k 0.9× 366 0.7× 255 0.7× 300 1.1× 159 0.7× 75 2.8k
Tokuhiro Chano Japan 31 1.4k 1.2× 498 0.9× 542 1.5× 203 0.7× 403 1.7× 108 2.7k
Hexige Saiyin China 28 1.2k 1.0× 328 0.6× 311 0.9× 97 0.3× 117 0.5× 82 2.1k
Mengmeng Liu China 27 1.0k 0.9× 194 0.3× 247 0.7× 183 0.6× 96 0.4× 127 2.6k
Xiaomei Yang China 37 2.0k 1.7× 583 1.0× 969 2.7× 384 1.4× 376 1.6× 111 3.6k
Xiaopeng Ma China 24 663 0.6× 310 0.6× 222 0.6× 204 0.7× 180 0.8× 128 2.0k

Countries citing papers authored by Bing Zou

Since Specialization
Citations

This map shows the geographic impact of Bing Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zou more than expected).

Fields of papers citing papers by Bing Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zou. The network helps show where Bing Zou may publish in the future.

Co-authorship network of co-authors of Bing Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Bing Zou. A scholar is included among the top collaborators of Bing Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing Zou. Bing Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yang, Yu Gao, Yuting Ye, et al.. (2025). N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus. PLoS Pathogens. 21(9). e1013463–e1013463. 1 indexed citations
2.
Chen, Dawei, Aiqin Gao, Bing Zou, et al.. (2024). Overall survival of adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line treatment for extensive-stage small cell lung cancer.. Journal of Clinical Oncology. 42(16_suppl). 8014–8014. 3 indexed citations
3.
Duan, Yang, et al.. (2023). PD-1 Inhibitors and Chemotherapy Combined with or without Radiotherapy for Patients with Oligometastatic Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e294–e295.
4.
Fang, Xiaowei, et al.. (2023). Tectorigenin relieved sepsis-induced myocardial ferroptosis by inhibiting the expression of Smad3. Toxicology Research. 12(3). 520–526. 19 indexed citations
5.
Li, Butuo, Linlin Yang, Huan Zhang, et al.. (2023). Outcome-Supervised Deep Learning on Pathologic Whole Slide Images for Survival Prediction of Immunotherapy in Patients with Non–Small Cell Lung Cancer. Modern Pathology. 36(8). 100208–100208. 5 indexed citations
6.
Wang, Chunni, et al.. (2023). Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer. Future Oncology. 19(19). 1367–1378. 2 indexed citations
7.
Zou, Bing, et al.. (2023). Pulmonary sarcoidosis-like reactions induced by sintilimab in esophageal cancer: A case report. Medicine. 102(31). e34432–e34432. 3 indexed citations
8.
Fan, Bingjie, Butuo Li, Haoqian Li, et al.. (2023). Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs. Cancer Management and Research. Volume 15. 351–362. 4 indexed citations
9.
Tao, Si, et al.. (2022). Gut microbiota mediates the inhibition of lymphopoiesis in dietary-restricted mice by suppressing glycolysis. Gut Microbes. 14(1). 2117509–2117509. 6 indexed citations
10.
Guo, Xiaohong, Jiajun Liu, Bing Zou, et al.. (2022). Effect of Biochar on Soil Physiochemical Properties and Bacterial Diversity in Dry Direct-Seeded Rice Paddy Fields. Agronomy. 13(1). 4–4. 12 indexed citations
11.
Cui, Hui, Taotao Dong, Bing Zou, et al.. (2021). Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer. Frontiers in Oncology. 11. 688706–688706. 8 indexed citations
12.
Tang, Duozhuang, et al.. (2020). Dietary restriction increases protective gut bacteria to rescue lethal methotrexate-induced intestinal toxicity. Gut Microbes. 12(1). 1714401–1714401. 32 indexed citations
13.
Zou, Bing, Alexandra A. DeSmidt, Rahul Mittal, et al.. (2019). The Generation of Zebrafish Mariner Model Using the CRISPR/Cas9 System. The Anatomical Record. 303(3). 556–562. 4 indexed citations
14.
DeSmidt, Alexandra A., Bing Zou, M’hamed Grati, et al.. (2019). Zebrafish Model for Nonsyndromic X‐Linked Sensorineural Deafness, DFNX1. The Anatomical Record. 303(3). 544–555. 18 indexed citations
15.
Tao, Si, et al.. (2019). High Canonical Wnt/β-Catenin Activity Sensitizes Murine Hematopoietic Stem and Progenitor Cells to DNA Damage. Stem Cell Reviews and Reports. 16(1). 212–221. 3 indexed citations
16.
17.
Wu, Dan, Qinghua Wu, Bing Zou, et al.. (2017). Knockdown of Long Non‐Coding RNA‐ZFAS1 Protects Cardiomyocytes Against Acute Myocardial Infarction Via Anti‐Apoptosis by Regulating miR‐150/CRP. Journal of Cellular Biochemistry. 118(10). 3281–3289. 77 indexed citations
18.
Tse, Man‐Kit, et al.. (2012). Domain organization of XAF1 and the identification and characterization of XIAPRING‐binding domain of XAF1. Protein Science. 21(10). 1418–1428. 12 indexed citations
19.
Dai, Yun, Liang Qiao, Kwok Wah Chan, et al.. (2008). Loss of XIAP sensitizes rosiglitazone‐induced growth inhibition of colon cancer in vivo. International Journal of Cancer. 122(12). 2858–2863. 32 indexed citations
20.
Qiao, Liang, Yun Dai, Qing Gu, et al.. (2008). Loss of XIAP sensitizes colon cancer cells to PPARγ independent antitumor effects of troglitazone and 15-PGJ2. Cancer Letters. 268(2). 260–271. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jung‐Min Kim Breakdown of academic impact, for papers by Xiaoyu Liu Breakdown of academic impact, for papers by Chia‐Cheng Chang Breakdown of academic impact, for papers by David J. Flint Breakdown of academic impact, for papers by Tokuhiro Chano Breakdown of academic impact, for papers by Hexige Saiyin Breakdown of academic impact, for papers by Mengmeng Liu Breakdown of academic impact, for papers by Xiaomei Yang Breakdown of academic impact, for papers by Xiaopeng Ma
Rankless by CCL
2026